Synthesis and reactions of N-methylbenzylammonium fluorochromate(VI) on silica gel, a selective and efficient heterogeneous oxidant.
N-Methylbenzylammonium fluorochromate(VI) (MBAFC) is easily synthesized by addition of N-methylbenzylamine to an aqueous solution of CrO3 and HF. MBAFC shows selectivity in the oxidation of aryl alcohols to their corresponding aldehydes and ketones under mild conditions. The durability, ease of work up and efficiency of MBAFC are considerably increased upon its absorption on silica gel.
A novel and active catalyst Ag/ZnO for oxidant-free dehydrogenation of alcohols
Abstract Nano Ag/ZnO catalysts were prepared by varying load of Ag on ZnO supports using a new and very simple method. The structure of nano Ag/ZnO has been confirmed by various techniques. The Ag/ZnO with 7.4 × 10 −5  mol% of Ag has pore size distribution about 2.74 nm and this nano Ag/ZnO is found to be the best catalyst for oxidation of primary and secondary benzyl alcohols into corresponding aldehydes and ketones in oxidant-free at the atmospheric pressure. The influence of various parameters such as: solvent, base, temperature, time of reaction, etc. has been systematically studied on nano Ag/ZnO catalyst.
Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
Imipramine inhibits the serotonin uptake by binding with high affinity to regulatory sites of this uptake located on axons that release serotonin. The number of imipramine recognition sites located on crude synaptic membrane preparations is reduced by two daily injections of imipramine or desmethylimipramine for 3 weeks. When the binding sites for [3H]imipramine are down-regulated the Vmax of the neuronal uptake of serotonin is increased. Moreover, in minces prepared from the brain hippocampus of rats receiving imipramine in a dose regimen that reduces the number of [3H]imipramine recognition sites, the efficiency of imipramine as a blocker of the serotonin uptake is diminished. Hence the high-affinity binding sites for [3H]imipramine may have a physiological role in modulation of serotonin reuptake. Probably this is mediated by an endogenous effector of these regulatory sites. A nonpeptidic constituent of rat brain capable of displacing [3H]imipramine from its high-affinity binding site and of inhibiting the serotonin uptake in a dose-related manner has been extracted and its partial purification is described.